BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34419497)

  • 1. miR-26a enhances colorectal cancer cell growth by targeting RREB1 deacetylation to activate AKT-mediated glycolysis.
    Chen B; Deng YN; Wang X; Xia Z; He Y; Zhang P; Syed SE; Li Q; Liang S
    Cancer Lett; 2021 Aug; 521():1-13. PubMed ID: 34419497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells.
    Chen B; Liu Y; Jin X; Lu W; Liu J; Xia Z; Yuan Q; Zhao X; Xu N; Liang S
    BMC Cancer; 2014 Jun; 14():443. PubMed ID: 24935220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell migration and proliferation are regulated by miR-26a in colorectal cancer via the PTEN-AKT axis.
    Coronel-Hernández J; López-Urrutia E; Contreras-Romero C; Delgado-Waldo I; Figueroa-González G; Campos-Parra AD; Salgado-García R; Martínez-Gutierrez A; Rodríguez-Morales M; Jacobo-Herrera N; Terrazas LI; Silva-Carmona A; López-Camarillo C; Pérez-Plasencia C
    Cancer Cell Int; 2019; 19():80. PubMed ID: 30983885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crocin Suppresses Colorectal Cancer Cell Proliferation by Regulating miR-143/145 and KRAS/RREB1 Pathways.
    Hosseini SS; Nazifi P; Amini M; Zargari F; Yari AH; Baradaran B; Mahboob S; Mokhtarzadeh A
    Anticancer Agents Med Chem; 2023; 23(17):1916-1923. PubMed ID: 37464834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
    Li Y; Sun Z; Liu B; Shan Y; Zhao L; Jia L
    Cell Death Dis; 2017 Jun; 8(6):e2892. PubMed ID: 28640257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA DLX6-AS1 Regulates the Growth and Aggressiveness of Colorectal Cancer Cells Via Mediating the miR-26a/EZH2 Axis.
    Kong WQ; Liang JJ; Du J; Ye ZX; Gao P; Liang YL
    Cancer Biother Radiopharm; 2021 Nov; 36(9):753-764. PubMed ID: 32379493
    [No Abstract]   [Full Text] [Related]  

  • 8. Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway.
    Xu J; Xiao Y; Liu B; Pan S; Liu Q; Shan Y; Li S; Qi Y; Huang Y; Jia L
    J Exp Clin Cancer Res; 2020 Mar; 39(1):54. PubMed ID: 32209115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
    Si Z; Yu L; Jing H; Wu L; Wang X
    J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.
    Kent OA; Fox-Talbot K; Halushka MK
    Oncogene; 2013 May; 32(20):2576-85. PubMed ID: 22751122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles-derived microRNA-222 promotes immune escape via interacting with ATF3 to regulate AKT1 transcription in colorectal cancer.
    Li S; Yan G; Yue M; Wang L
    BMC Cancer; 2021 Apr; 21(1):349. PubMed ID: 33794833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.
    Wu YC; Li SY; Jia YF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-26a inhibits wound healing through decreased keratinocytes migration by regulating ITGA5 through PI3K/AKT signaling pathway.
    Jiang Z; Wei J; Yang W; Li W; Liu F; Yan X; Yan X; Hu N; Li J
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32955094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Metformin, Sodium Oxamate and Doxorubicin Induces Apoptosis and Autophagy in Colorectal Cancer Cells
    Coronel-Hernández J; Salgado-García R; Cantú-De León D; Jacobo-Herrera N; Millan-Catalan O; Delgado-Waldo I; Campos-Parra AD; Rodríguez-Morales M; Delgado-Buenrostro NL; Pérez-Plasencia C
    Front Oncol; 2021; 11():594200. PubMed ID: 34123772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
    Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-26a/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1.
    Wei Z; Chang K; Fan C; Zhang Y
    Cancer Cell Int; 2020; 20():82. PubMed ID: 32190006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis.
    Zhang M; Duan W; Sun W
    Onco Targets Ther; 2019; 12():3349-3360. PubMed ID: 31118686
    [No Abstract]   [Full Text] [Related]  

  • 18. CircCDC6 restrains tumor growth and glycolysis energy metabolism in colorectal cancer via regulating miR-3187-3p and downstream PRKAA2.
    Zhao C; Chen H; Min K
    J Bioenerg Biomembr; 2022 Jun; 54(3):163-174. PubMed ID: 35438362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.
    Liu B; Wu X; Liu B; Wang C; Liu Y; Zhou Q; Xu K
    Biochim Biophys Acta; 2012 Nov; 1822(11):1692-704. PubMed ID: 22885155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis.
    Fu X; Meng Z; Liang W; Tian Y; Wang X; Han W; Lou G; Wang X; Lou F; Yen Y; Yu H; Jove R; Huang W
    Oncogene; 2014 Aug; 33(34):4296-306. PubMed ID: 24056962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.